Create accountLogin

Recent searches

No recent searches

Search options

Only available when logged in.
freiburg.social is one of the many independent Mastodon servers you can use to participate in the fediverse.
Ein Mastodon-Server für Freiburg und Umland betrieben durch den Verein freiburg.social e.V.: https://wir.freiburg.social

Administered by:

Server stats:

532
active users

freiburg.social: AboutProfiles directoryPrivacy policy

Mastodon: AboutGet the appKeyboard shortcutsView source codev4.3.4

#rsvvaccine

0 posts0 participants0 posts today
Auscandoc<p><a href="https://med-mastodon.com/tags/RSVvaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSVvaccine</span></a> for Canada's seniors approved | CTV News <a href="https://www.ctvnews.ca/health/canada-approves-moderna-s-rsv-vaccine-for-adults-aged-60-and-older-1.7103111" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">ctvnews.ca/health/canada-appro</span><span class="invisible">ves-moderna-s-rsv-vaccine-for-adults-aged-60-and-older-1.7103111</span></a> “<a href="https://med-mastodon.com/tags/HealthCanada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HealthCanada</span></a> has approved the vaccine, <a href="https://med-mastodon.com/tags/mRESVIA" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mRESVIA</span></a>, for prevention of lower respiratory tract disease in older adults, the company said, adding that its supply is expected in early 2025.”</p>
Auscandoc<p>Pfizer’s <a href="https://med-mastodon.com/tags/RSVVaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSVVaccine</span></a> for older adults, pregnant people approved by Health Canada - <a href="https://globalnews.ca/news/10203419/pfizer-rsv-vaccine-pregnant-people-health-canada/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">globalnews.ca/news/10203419/pf</span><span class="invisible">izer-rsv-vaccine-pregnant-people-health-canada/</span></a> “<a href="https://med-mastodon.com/tags/HealthCanada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HealthCanada</span></a> on Thursday approved another respiratory syncytial virus (<a href="https://med-mastodon.com/tags/RSV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSV</span></a>) vaccine for adults over the age of 60 and pregnant people.</p><p>Pfizer’s bivalent RSV vaccine, <a href="https://med-mastodon.com/tags/Abrysvo" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Abrysvo</span></a>, has been authorized for the use of pregnant individuals from 32 through 36 weeks gestational age for the prevention of lower respiratory tract disease caused by RSV in <a href="https://med-mastodon.com/tags/infants" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>infants</span></a> from birth through six months”</p>
Auscandoc<p>Regular RSV vaccines would reduce deaths: study | CTV News <a href="https://www.ctvnews.ca/health/here-s-what-would-happen-if-rsv-vaccines-were-like-flu-shots-1.6709095" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">ctvnews.ca/health/here-s-what-</span><span class="invisible">would-happen-if-rsv-vaccines-were-like-flu-shots-1.6709095</span></a> “If respiratory syncytial virus (RSV) vaccines were given to people aged 60 and older like a flu shot, it would "dramatically" reduce illness and death, a new study says.</p><p>Published on Tuesday in the Journal of Clinical Infectious Diseases, … found if 66 per cent of the older adult population was given an <a href="https://med-mastodon.com/tags/RSVVaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSVVaccine</span></a>, it would decrease the burden of patients on the <a href="https://med-mastodon.com/tags/HealthCare" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HealthCare</span></a> system.”</p>
Auscandoc<p><a href="https://med-mastodon.com/tags/RSVvaccine" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSVvaccine</span></a> for older <a href="https://med-mastodon.com/tags/Canadians" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Canadians</span></a> comes at a cost. <a href="https://globalnews.ca/news/10001009/rsv-vaccine-cost-older-canadians-cost/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">globalnews.ca/news/10001009/rs</span><span class="invisible">v-vaccine-cost-older-canadians-cost/</span></a> “On Aug. 4, <a href="https://med-mastodon.com/tags/HealthCanada" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HealthCanada</span></a> approved the first vaccine for <a href="https://med-mastodon.com/tags/RSV" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>RSV</span></a> for adults aged 60 and over. The vaccine called <a href="https://med-mastodon.com/tags/Arexvy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Arexvy</span></a>, made by drug company GSK, has been shown to be 82-per cent effective at preventing lower respiratory tract disease caused by RSV.</p><p>The vaccine is scheduled to roll out sometime in October. It is not publicly funded (in most provinces), meaning most older Canadians may have to pay out of pocket for it.”</p>
ExploreLive feeds
About